Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 6, 2008 - Issue 4
Submit an article Journal homepage
339
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Tailor-made therapy for the prevention of acute coronary syndromes: future role of biomarkers in risk stratification and disease management

Rohit M Oemrawsingh Erasmus Medical Center, Department of Cardiology – Clinical Epidemiology Unit, ‘s Gravendijkwal 230, BA-561, 3015 CE Rotterdam, The Netherlands. [email protected]
,
K Martijn Akkerhuis Cardiologist, Erasmus Medical Center, Department of Cardiology, Rotterdam, The Netherlands. [email protected]
&
Eric Boersma Associate Professor of Clinical Cardiovascular Epidemiology, Erasmus Medical Center, Department of Cardiology – Clinical Epidemiology Unit, Rotterdam, The Netherlands
Pages 435-437 | Published online: 10 Jan 2014

References

  • Cambridge, Harvard School of Public Health on behalf of the World Health Organization and The World Bank. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Murray CJL, Lopez AD (Eds). Global Burden of Disease and Injury Series, Volume I (1996).
  • Okrainec K, Banerjee DK, Eisenberg MJ. Coronary artery disease in the developing world. Am. Heart J.148(1), 7–15 (2004).
  • Liu JL, Maniadakis N, Gray A, Rayner M. The economic burden of coronary heart disease in the UK. Heart88, 597–603 (2002).
  • Bassand JP, Hamm CW, Ardissino D et al. Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur. Heart J.28(13), 1598–660 (2007).
  • Van de Werf F, Ardissino D, Betriu A et al.; Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur. Heart J.24(1), 28–66 (2003).
  • Rovelli F, De Vita C, Feruglio GA, Lotto A, Selvini A, Tognoni G. GISSI trial: early results and late follow-up. Gruppo Italiano per la Sperimentazione della Streptochinasi nell’Infarto Miocardico. J. Am. Coll. Cardiol.10(5 Suppl. B), 33B–39B (1987).
  • Grijseels EW, Bouten MJ, Lenderink T et al. Pre-hospital thrombolytic therapy with either alteplase or streptokinase. Practical applications, complications and long-term results in 529 patients. Eur. Heart J.16(12), 1833–1838 (1995).
  • Boersma E. The Primary Coronary Angioplasty vs Thrombolysis Group. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients.Eur. Heart J.27(7), 779–788 (2006).
  • Ross R. Atherosclerosis – an inflammatory disease. N. Engl. J. Med.14340(2), 115–126 (1999).
  • Libby P. Inflammation in atherosclerosis. Nature420, 868–874 (2002).
  • Werner N, Kosiol S, Schiegl T et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med.353(10), 999–1007 (2005).
  • Libby P. Atherosclerosis: disease biology affecting the coronary vasculature. Am. J. Cardiol.98(12A), 3Q–9Q (2006).
  • LaDue JS, Wroblewski F, Karmen A. Serum glutamic oxaloacetic transaminase activity in human acute transmural myocardial infarction. Science120(3117), 497–499 (1954).
  • Lenderink T, Heeschen C, Fichtlscherer S et al. CAPTURE Investigators. Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes. J. Am. Coll. Cardiol.47(2), 307–311 (2006).
  • Anwaruddin S, Askari AT, Topol EJ. Redefining risk in acute coronary syndromes using molecular medicine. J. Am. Coll. Cardiol.49(3), 279–289 (2007).
  • Pearson TA, Mensah GA, Alexander RW et al. Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation107(3), 499–511 (2003).
  • Michelson AD, Frelinger AL 3rd, Furman MI. Current options in platelet function testing. Am. J. Cardiol.98(10A), 4N–10N (2006).
  • Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med.354, 610–621 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.